GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Valuation Rank

Althea Group Holdings (Althea Group Holdings) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Althea Group Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Althea Group Holdings (Althea Group Holdings) Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.